These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2780003

  • 1. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
    Camras CB, Siebold EC, Lustgarten JS, Serle JB, Frisch SC, Podos SM, Bito LZ.
    Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes.
    Groeneboer MC, Hoyng PF, Kuizenga A.
    Curr Eye Res; 1989 Feb; 8(2):131-8. PubMed ID: 2540937
    [Abstract] [Full Text] [Related]

  • 4. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
    Toris CB, Camras CB, Yablonski ME.
    Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
    [Abstract] [Full Text] [Related]

  • 5. Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients.
    Lee PY, Shao H, Camras CB, Podos SM.
    Ophthalmology; 1991 Jul; 98(7):1079-82. PubMed ID: 1891217
    [Abstract] [Full Text] [Related]

  • 6. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
    Ziai N, Dolan JW, Kacere RD, Brubaker RF.
    Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.
    Bito LZ, Miranda OC, Tendler MR, Resul B.
    Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ocular effects of two different prostaglandin F2 alpha esters. A doublemasked cross-over study on normotensive eyes.
    Villumsen J, Alm A.
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):341-3. PubMed ID: 2392914
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of two dose regimens of latanoprost in patients with elevated intraocular pressure.
    Lusky M, Ticho U, Glovinsky J, Weinberger D, Nesher R, Yassur Y, Melamed S.
    Ophthalmology; 1997 Oct; 104(10):1720-4. PubMed ID: 9331215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of apraclonidine on aqueous humor dynamics in human eyes.
    Toris CB, Tafoya ME, Camras CB, Yablonski ME.
    Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
    Toris CB, Zhan G, Camras CB.
    Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
    [Abstract] [Full Text] [Related]

  • 18. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
    Toris CB, Zhan G, Fan S, Dickerson JE, Landry TA, Bergamini MV, Camras CB.
    J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
    [Abstract] [Full Text] [Related]

  • 19. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
    Goh Y, Nakajima M, Azuma I, Hayaishi O.
    Jpn J Ophthalmol; 1988 Mar; 32(4):471-80. PubMed ID: 3236567
    [Abstract] [Full Text] [Related]

  • 20. The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma.
    Prünte C, Flammer J.
    Ophthalmology; 1995 Sep; 102(9):1291-7. PubMed ID: 9097765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.